The "Forgotten" Subtypes of Breast Carcinoma: A Systematic Review of Selected Histological Variants Not Included or Not Recognized as Distinct Entities in the Current World Health Organization Classification of Breast Tumors.

Post hoc analysis showed that (a) patients with LELC had better survival than patients with MBCMD ( p = 0.0027) (b) patients with LELC had no difference in survival compared to patients with BCOGC ( p = 1) (c) patients with LELC had better survival from patients with SRCC ( p = 0.009) (d) patients with MBCMD had worst survival from patients with BCOGC ( p = 0.0027) but (e) no difference was confirmed when compared to patients with SRCC and finally (f) a marginal significance ( p = 0.091) was detected when comparing patients with BCOGC with those having SRCC the latter having worst survival probability.

also in 5,069 other papers